14th February 2022 | Pharma Updates
Delhi State Cancer Institute partners with Roche Pharma
Roche has inked an MoU with Delhi State Cancer Institute to ensure quality cancer treatment in India’s capital.
SaNOtize to Sell Nasal Spray In India
SaNOtize has received a nod from India’s drug regulator. NONS helps treat Covid patients with mild symptoms.
Bebtelovimab for Covid Patients
Bebtelovimab is a novel monoclonal antibody developed by AbCellera and Eli Lilly and Company.
BCMA CAR-T Cell Therapy Receives Orphan Drug Designation
US’s drug regulator has granted orphan drug designation to anti-Bcell maturation antigen chimeric antigen receptor T-cell therapy developed by IASO Bio and Innovent.
New Implant Device to Treat Patients with CHF
The device is inserted into the pulmonary artery that changes the pressure on the healthy right ventricle, enabling it to support the failed left ventricle.
MHRA plan to help menopause symptom with OTC drug
UK government proposal to make certain hormone replacement therapy drugs available has been seen as a good move.
First batch of Paxlovid pills arrives in Singapore
Pfizer’s first oral antiviral drug has been okayed by the Health Sciences Authority for the treatment of Covid patients.
Birth control pill no longer requires a prescription from a doctor in North Carolina
Pharmacists in North Carolina are now eligible to dispense birth control pills and birth control patches.
OxVent ventilator to help UK's Covid patients
OxVent Social Enterprise has now secured ISO 13485 certification for its QMS.
FDA okays Investigational Device Exemption application for medical diagnosis
According to Check-Cap, the software generates a 3D map of the inner lining of the colon along the gastrointestinal tract.
